fda tirzepatide lawsuit US judge sides with FDA's removal of Lilly's weight loss drug from shortage list The Legal Battle Over Tirzepatide:

The attack reportedly occurred in the Ghouta region and killed dozens, including women and children

Tachycardia from Zepbound is rare

These analyses, across the spectrum of clinical trial programs conducted to evaluate semaglutide, add to our understanding of the critical ways semaglutide may impact those complications, with the goal of going beyond weight loss to improvements in overall health. Novo Nordisk notes that these exploratory post hoc analyses are hypothesis-generating, and further work investigating the clinical validity of the results would be of value

Lastly, obesity is a risk factor for venous thromboembolism (VTE)